Missed out on attending the British Society for Parasitology’s Autumn Symposium? Read our report of the event here, including talks from Roy Anderson and David Molyneux.
Browsing: Parasitic > Neglected Tropical Diseases
Editor, Martha Powell, discusses the issues around the current guidance for treating HAT and gives an overview of the current clinical pipeline being spearheaded by the Drugs for Neglected Diseases initiative.
In line with our focus this month on zoonoses, we spoke to Joanne Webster from the Royal Veterinary College, about her involvement in a host of projects on zoonotic parasites, including both schistosomiasis and Toxoplasma.
In this exclusive piece, the authors look at antihelmintics in both animal and human health – arguing that evolution of resistance necessitates drug development.
New research has demonstrated that the extent of Leishmania infection cycles in line with host circadian rhythms, presenting an opportunity for new therapeutics and optimizing prevention methods.
More than a century after its description and the discovery of the bacterial etiological agent, and despite its major burden globally, leptospirosis remains largely under-recognized.
Researchers have demonstrated that leishmania infection causes dysbiosis in the skin microbiota of both humans and mice. Moreover, in mice they discovered this dybiosis can be passed to naïve mice after close contact with infected individuals.
Chagas disease displays different parasitic stages, phases of disease and consequently special diagnostic needs, leading to underdiagnosis and further spread to non-endemic countries. Find out more in this exclusive piece.
It may be possible to interrupt the transmission of soil-transmitted helminths, which affect nearly 2 billion individuals globally. Here, the authors give an overview of the DeWorm3 project, which aims to test the feasibility of interrupting soil-transmitted helminth transmission.